Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Drug Settlements May Help Fund Mental Health Initiatives

March 11, 2011 6:35 am | by Molly Davis | News | Comments

Mississippi Attorney General Jim Hood said he hopes that lawmakers will use $20.2 million that the state received from settling its lawsuit against pharmaceutical companies to fund mental health programs next year.

TOPICS:

S & P Ups Mylan Credit Rating

March 11, 2011 6:31 am | News | Comments

Generic drug developer Mylan Inc. said that Standard & Poor's Ratings Services upgraded the company's corporate credit ratings, citing its use of cash flow to cut its debt load.

TOPICS:

New Vertex Epilepsy Drug Tests Safe

March 11, 2011 6:28 am | News | Comments

Vertex Pharmaceuticals Inc. said that VX-765 met key safety and tolerability goals in a midstage study. The six-week trial included 60 people with treatment-resistant epilepsy, a type of epilepsy where seizures start and occur in a specific part of the brain.

TOPICS:
Advertisement

Monthly Byetta Doing Well in Latest Trial

March 11, 2011 6:26 am | News | Comments

Drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said a monthly version of the diabetes treatment Byetta performed positively in a small, mid-stage study that measured its effectiveness, safety and tolerability.

TOPICS:

FDA Bars Operations at Troubled J & J Plant

March 11, 2011 6:23 am | by Matthew Perrone | News | Comments

Federal officials said that the consumer health unit of Johnson & Johnson will be barred from resuming operations at a Pennsylvania manufacturing plant linked to millions of bottles of defective medicines until it meets quality standards.

TOPICS:

Label Printer-Applicator

March 10, 2011 7:51 am | Product Releases | Comments

The Tharo PA2000 Specialty Tamp Label Printer/Applicator requires minimal adjustments and has a quick setup and changeover for applying labels to the top or side of varying height products.

TOPICS:

Translational Medicine Platform

March 10, 2011 7:39 am | Product Releases | Comments

IDBS will provide an enterprise translational medicine platform for the Integrated Cancer Centre at King’s Health Partners to develop targeted, personalized, cancer therapies.

TOPICS:

Grace Davison Opens New Facility in India

March 10, 2011 7:27 am | News | Comments

Grace Davison Discovery Sciences announced the opening of a new technical service Knowledge Centre in Southern India for customers in the pharmaceutical and biotechnology industries.

TOPICS:
Advertisement

Epizyme Working with Eisai on EZH2 Drugs

March 10, 2011 7:22 am | News | Comments

Epizyme, Inc. announced a worldwide partnership with Eisai Co., Ltd., Tokyo, Japan to discover, develop and commercialize therapeutics targeting EZH2, an epigenetic enzyme, for the treatment of lymphoma and other cancers in genetically-defined patients.

TOPICS:

Injecting Degludec Every Other Day Just As Effective

March 10, 2011 7:17 am | News | Comments

A study assessing a new longer-acting form of insulin—degludec— has shown that patients could achieve the same level of glucose control when the insulin was administered just three times a week instead of daily.

TOPICS:

Relapsed ALL Often Resistant to Steroid Treatment

March 10, 2011 7:11 am | News | Comments

Relapse remains a leading cause of death from childhood acute lymphoblastic leukemia and newly identified mutations in a gene named CREBBP may be helping the cancer resist steroid treatment and fueling ALL's return.

TOPICS:

Biotron Completes First Part of Phase 2 Trial

March 10, 2011 7:06 am | News | Comments

Australian drug development company Biotron Limited has completed stage one of a landmark human trial of its lead Hepatitis C drug candidate, BIT225.

TOPICS:

Lucentis Trial Shows Greatly Improved Vision in DME

March 10, 2011 7:04 am | News | Comments

Genentech announced that two-year results from a pivotal Phase 3 trial showed patients with diabetic macular edema who received Lucentis experienced rapid and sustained improvement in vision compared to those who received a placebo injection.

TOPICS:

Mutation Could Make Swine Flu Far Deadlier

March 10, 2011 7:00 am | News | Comments

In the fall of 1917, a new strain of influenza swirled around the globe. At first, it resembled a typical flu epidemic. However, in the summer of 1918, a deadlier version of the same virus began spreading, killing 50 million people.

TOPICS:

Scientists Find Compound to Attack Pancreatic Cancer

March 10, 2011 6:56 am | News | Comments

Researchers have identified a chemical compound that may eventually lead to a drug that fights cancers that are dependent on a particular anti-viral enzyme for growth.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading